RxPONDER trial will evaluate whether gene expression test can drive chemotherapy choice
Tuesday, April 26, 2011 - 09:00
in Health & Medicine
Cancer researchers at hundreds of sites nationwide are about to launch a SWOG-led clinical trial that could keep thousands of breast cancer patients from getting chemotherapy that is unlikely to do them any good.